Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial

BACKGROUND: Ascorbic acid (AA) has in vivo cytotoxic properties at concentrations that can only be achieved through intravenous (IV) administration in humans. Treatment with intravenous AA is widely and increasingly used in complementary medicine despite a lack of clinical evidence for the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Torben K., Højgaard, Martin, Andersen, Jon T., Jørgensen, Niklas Rye, Zerahn, Bo, Kristensen, Bent, Henriksen, Trine, Lykkesfeldt, Jens, Mikines, Kári J., Poulsen, Henrik E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503969/
https://www.ncbi.nlm.nih.gov/pubmed/28725594
http://dx.doi.org/10.21037/tau.2017.04.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503969/
https://www.ncbi.nlm.nih.gov/pubmed/28725594
http://dx.doi.org/10.21037/tau.2017.04.42

Ejemplares similares